A comprehensive overview of patient journey and management decision pathway for myelofibrosis in India: INLAND survey
Abstract Background Myelofibrosis is a myeloproliferative neoplasm characterized by stem cell-derived clonal myeloproliferative and anomalous production of cytokines with genetic mutations in the JAK/STAT signalling pathway playing a distinctive role in its pathophysiology. Diagnosis of MF presents...
Saved in:
| Main Authors: | Prantar Chakrabarti, Abhay Bhave, Claire Harrison, Tulika Seth, Vikram Mathews, Disha Shetty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14476-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
by: O. Yu. Vinogradova, et al.
Published: (2023-12-01) -
Complicated course of portal hypertension on the background of primary myelofibrosis: a clinical case
by: V.B. Yagmur, et al.
Published: (2025-03-01) -
CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS
by: E. G. lisina, et al.
Published: (2017-10-01) -
Tuberculosis reactivation related with ruxolitinib in a patient with primary myelofibrosis
by: Mehmet S Pepeler, et al.
Published: (2018-10-01) -
Case Report: A novel t(15;17)(q24;q11.2) translocation involving NF1::SCAMP5 fusion in a patient with myeloproliferative neoplasms
by: Yuying Chang, et al.
Published: (2025-07-01)